K. Symons

发表

DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras.

B. Cravatt, T. Wucherpfennig, M. Dix, 2021, Journal of the American Chemical Society.

Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases

Nahid M. Yazdani, T. Rao, A. Shiau, 2011, Journal of Pharmacology and Experimental Therapeutics.

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

A. Saven, T. Rao, J. Malecha, 2008, Molecular Cancer Therapeutics.

Alpha-mercaptoketone based histone deacetylase inhibitors.

J. Malecha, T. Z. Hoffman, B. Wiley, 2008, Bioorganic & medicinal chemistry letters.

Identification of KD5170: a novel mercaptoketone-based histone deacetylase inhibitor.

T. Rao, J. Malecha, T. Z. Hoffman, 2008, Bioorganic & medicinal chemistry letters.

Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.

Nahid M. Yazdani, J. Walsh, T. Rao, 2009, Journal of medicinal chemistry.

Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.

Nahid M. Yazdani, T. Rao, A. Shiau, 2012, Bioorganic & medicinal chemistry letters.

Inhibition of Inducible Nitric Oxide Synthase Expression by a Novel Small Molecule Activator of the Unfolded Protein Response

T. Rao, A. Shiau, C. Hassig, 2008, Current chemical genomics.

KD 5170 , a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

A. Saven, T. Rao, J. Malecha, 2008 .

Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS

Nahid M. Yazdani, T. Rao, A. Shiau, 2010, Journal of medicinal chemistry.

KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization

T. Rao, A. Shiau, C. Hassig, 2009, Molecular Pharmacology.